AIRLINK 75.50 Increased By ▲ 1.00 (1.34%)
BOP 4.73 No Change ▼ 0.00 (0%)
CNERGY 4.18 Increased By ▲ 0.04 (0.97%)
DFML 40.12 Increased By ▲ 0.77 (1.96%)
DGKC 88.80 Increased By ▲ 3.90 (4.59%)
FCCL 22.99 Increased By ▲ 1.09 (4.98%)
FFBL 30.47 Increased By ▲ 0.26 (0.86%)
FFL 9.23 Decreased By ▼ -0.02 (-0.22%)
GGL 10.14 Decreased By ▼ -0.26 (-2.5%)
HASCOL 6.20 Decreased By ▼ -0.13 (-2.05%)
HBL 106.50 Decreased By ▼ -1.75 (-1.62%)
HUBC 140.10 Decreased By ▼ -0.15 (-0.11%)
HUMNL 10.59 Increased By ▲ 0.29 (2.82%)
KEL 4.77 Decreased By ▼ -0.03 (-0.63%)
KOSM 4.39 Decreased By ▼ -0.03 (-0.68%)
MLCF 38.40 Increased By ▲ 0.90 (2.4%)
OGDC 123.60 Decreased By ▼ -1.04 (-0.83%)
PAEL 24.62 Increased By ▲ 0.18 (0.74%)
PIBTL 6.10 Decreased By ▼ -0.10 (-1.61%)
PPL 114.30 Decreased By ▼ -2.10 (-1.8%)
PRL 24.06 Decreased By ▼ -0.54 (-2.2%)
PTC 13.05 Decreased By ▼ -0.08 (-0.61%)
SEARL 59.60 Increased By ▲ 3.61 (6.45%)
SNGP 61.80 Decreased By ▼ -1.18 (-1.87%)
SSGC 9.66 Decreased By ▼ -0.21 (-2.13%)
TELE 7.85 Decreased By ▼ -0.14 (-1.75%)
TPLP 10.07 Increased By ▲ 0.14 (1.41%)
TRG 65.20 Increased By ▲ 0.70 (1.09%)
UNITY 26.90 Increased By ▲ 0.24 (0.9%)
WTL 1.34 Increased By ▲ 0.02 (1.52%)
BR100 7,694 Decreased By -23.6 (-0.31%)
BR30 24,691 Decreased By -86.7 (-0.35%)
KSE100 73,754 Decreased By -108.9 (-0.15%)
KSE30 23,617 Decreased By -74.6 (-0.31%)

Former Prime Minister and Pakistan Muslim League-Nawaz (PML-N) supremo Nawaz Sharif has left for home after his check up at London Bridge Hospital.

The former Prime Minister's son Hussain Nawaz, his personal doctor Dr Adnan and Leader of Opposition in National Assembly and PML-N president Shehbaz Sharif accompanied him.

Talking to media persons in London on Monday, Shehbaz Sharif said that they were waiting for the reports of medical examinations, adding that the doctors would reach decision after going through elder Sharif's reports.

To a question, Shehbaz said that he never responds to Federal Minister for Railways Sheikh Rasheed Ahmed's statement.

Copyright Independent News Pakistan, 2019

Comments

Comments are closed.